Wenzel Novak, PhD, began his career working on keratinocytes for wound healing as head of laboratory in a Swiss biotech-company. He then joined Gerresheimer in charge of project management and, as head of production for presterilised syringes, he designed the manufacturing area, built up the process and quality systems and operated the start-up phase of production. He then took role as Chief Innovation Officer at a pharmaceutical equipment supplier, developing new methods of sterilisation and filling processes. During two years spent working in the US, he developed the market for cell and gene therapy equipment. In 2018, Dr Novak returned to Gerresheimer in a new global senior role for business development. He studied biology and gained his PhD in physics at the Max Planck Institute for Neurochemistry (Munich, Germany).